Click here to view the Disclaimer. Click here to return to the list of AHG documents. The definitions of the following terms were discussed by or proposed to the Ad Hoc Group and may need further consideration in the context of specific measures. The appearance of any term on this list is without prejudice to whether that term has either an acceptable definition content or is acceptable for inclusion in any final legally binding instrument. Other characteristics could also include buildings sealable for decontamination, with a ventilation system that establishes a directional airflow from the access space into the laboratory room, double door entry into the room, sealable windows and effluent disinfected.
Equipment used inside include biosafety cabinets and specialised autoclaves.
System A system, which physically separates the process from the environment with seals so as to prevent release of organisms from the system, exhaust gases from the system are treated so as to prevent release and effluent is treated before final discharge. Sample collection, addition of material to the system and transfer of viable organisms to another system, is performed so as to prevent release. This system could be located within a controlled area. Production capability Expertise and capability to produce microbial or other biological agents or toxins, whatever their origin or method of production. Vaccine Preparations, including liveattenuated, killed or otherwise modified organisms or their components, and nucleic acids, which when introduced by any of multiple routes into a human being or animal induces in it an active immune response for prophylactic or protective use.